Loading...
Soliton, Inc.
SOLY•NASDAQ
HealthcareMedical - Devices
$22.58
$0.00(0.00%)
Soliton, Inc. (SOLY) Stock Overview
Explore Soliton, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Stats data is not available for SOLYStats details for SOLY are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations data is not available for SOLYAnalyst Recommendations details for SOLY are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Company Profile
Soliton, Inc., a medical device company, develops and commercializes products using a proprietary rapid acoustic pulse technology platform. The company offers products for the removal of tattoos. It also develops a product for cellulite reduction, fibrotic scar treatment, and other indications. The company was incorporated in 2012 and is based in Houston, Texas. As of December 16, 2021, Soliton, Inc. operates as a subsidiary of Allergan plc.
CEO
Dr. Christopher C. Capelli
Employees
13
Headquarters
5304 Ashbrook Dr, Houston, TEXAS
Founded
2019